This information on the Joslin website
does beg some questions. Are they really enthused about the “Joslin
Everywhere” program? Or will this become an untenable drain on the
funds and be kicked to the curb and abandoned like so many other
projects? This article on the Joslin website sounds great and I wish
them success. I will be watching and hopefully there will be some
transparency. The introduction to the article sounds impressive,
“Catherine Carver, M.S., A.N.P., C.D.E.,
Vice President for Advocacy and Planning is one of the key movers
behind Joslin’s bid to bring diabetes care into the 21st century
with Joslin Everywhere, a digital care and education platform in the
works at Joslin Diabetes Center.”
The next paragraph sounds even more
impressive. It says, “Imagine Joslin’s
resources being available to everybody, anywhere, on their phone, on
their computer or tablet, by live video chat. But not as
boilerplate, instead, in a form tailored to the patient’s
individual needs. For example, suppose the patient is Mexican and
wants to know about nutrition and diabetes- Joslin Everywhere would
present him with food choices in Spanish that are common to the
Mexican food mores. Expanding beyond face-to-face office visits is
the only way we can remain relevant in the face of the tsunami of new
diabetes cases coming our way. The only way we can hope to stem this
epidemic is to reach people through other mediums.”
Since this is still “in the works,” words to watch are
“boilerplate” and “patient's individual needs.”
The example really says nothing other
than they will use the person's language and nothing about not
boilerplating for the average Mexican. The food choices may
still be heavy on carbohydrates and low fat. Also, there is no
mention about having the patient use a blood glucose meter to see if
what they recommend causes blood glucose to spike. This begs another
question of what will be the effects for people with diabetes. Will
it mean more platitudes and then the one size fits all whole grains,
low fat mantra. Will we see more emphasis on testing to help people
manage their prediabetes to prevent type 2 diabetes – this is
highly unlikely.
Or will Joslin make use of some of the
new information to test people early to prevent even prediabetes.
“Researchers at Sweden's Lund University
have identified a "promising candidate" for a test that
will indicate an early risk for type 2 diabetes, up to 10 years
before diagnosing diabetes.” If
Joslin is sincere in reaching people through other mediums to stop
the diabetes epidemic, this should be on the table quickly for
evaluation and if it works, all doctors throughout the world should
make use of it. However, I doubt Joslin will be this progressive.
Is this only for Joslin patients? And
the next question - how is Joslin being reimbursed or paid?
Initially this is all it can be as there are many hoops to jump
through to be reimbursed for time spent. In the state of
Massachusetts, there is a law in place effective November 5, 2012
that states: “Alternative payments have the potential to provide
incentives for efficiency in the delivery of services that are absent
in the fee-for-service system, while potentially promoting
improvements in quality through better coordination of care.”
In other words, private insurers are beginning to understand there
are benefits of touching patients in the best venue for the patient.
This often means reduced costs for the insurer in the long-term.
As I learn more, I may have more
questions.
No comments:
Post a Comment